Business
Plasmagen Biosciences Enters Niche Indian Biopharmaceutical Market with CSL’s Haemocomplettan® P Launch
Mumbai, 25th June 2024: Plasmagen Biosciences Private Limited (“Plasmagen”), the Indian biopharmaceutical organization, headquartered in Bengaluru, specializing exclusively in Plasma Protein and Speciality Care Therapy, has recently announced the launch of Haemocomplettan® P (Human Fibrinogen […]